Video

Q&A With Farouc Jaffer From Massachusetts General Hospital: Finding More Connections Between Depression and Cardiac Conditions

Author(s):

Patients with chronic total occlusion percutaneous intervention may also be at risk of developing depression. Research has shown by treating the cardiac condition it can help lesson the symptoms of the psychiatric condition as well.

Patients with chronic total occlusion percutaneous intervention may also be at risk of developing depression. Research has shown by treating the cardiac condition it can help lesson the symptoms of the psychiatric condition as well.

Farouc A. Jaffer, MD, PhD, from Massachusetts General Hospital discussed research done in this field during the American Heart Association's annual scientific sessions in Orlando. While noting the potential of a chicken and egg effect, Jaffer noted studies on this connection can be difficult when identifying the proper patient population. Despite those issues he noted potential for successes when working across many areas of the health care field.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.